Approval · Notice of Compliance 8256 · 2006
NORLEVO: Notice of Compliance 8256
Issued September 13, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8256
- Date
- September 13, 2006
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Emergency contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORLEVO | 02285576 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB